Jakob Testad has his education from the School of Economics and Business Administration at Lund University and has been involved in Hamlet BioPharma since the company’s IPO 2015. Jakob has been Chief Financial Officer of Hamlet BioPharma since 2023.
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB Klinikgatan 32 SE-222 42 Lund info@hamletbiopharma.com Org. no. 556568-8958
Subscribe to receive Pressreleases and Newsletters
